All dog owners eventually come to understand one thing: The time we get to spend with these devoted pets is far too short.
But Celine Halioua thinks she can help dogs get a few more years out of life. The scientist, Oxford Ph.D. dropout and former chief of staff at a VC fund focused on longevity has spent nearly six years building Loyal, a California-based startup developing drugs to delay canine aging.
While that might sound too good to be true, Loyal has seen real progress, and the company’s first beef-flavored longevity pill could hit the market by next year.
Halioua is already in conversations with the FDA and has cleared some early hurdles for Loyal’s drug, which changes the metabolism of dogs ages 10 and up to mimic a low-calorie diet and has been shown to extend their lives. The company is also working on a pill and shot to lengthen the lifespans of larger dogs, which tend to be shorter.
Read more about Loyal in senior editor Amy Feldman’s latest story here. The startup is part of Forbes’ Next Billion-Dollar Startups 2025 list, and keep scrolling below for more in-depth journalism from our newsroom. |
|
